ABSTRACT
Five-year follow-up of an organized population of males between 35 and 54 years of age and medication of patients with arterial hypertension (AH) demonstrated possibilities of considerably reducing the incidence of cerebral insult (by 42.9%) and myocardial infarction (by 15.5%) and the respective mortality rates (by 56.1% and 23.8%), invalidism associated with cardiovascular diseases (by 36%), temporary disability because of AH (by 38.2%). The efficiency of treatment for AH increases considerably where medication is given on a regular basis. Possible approaches to improving the efficiency of secondary AH prevention within an organized population are discussed, as are possibilities of introducing preventive measures in routine work of the factory therapeutic service.